T1	AdverseReaction 55 99	Post-Transplant Lymphoproliferative Disorder
T2	AdverseReaction 101 105	PTLD
T3	Factor 119 123	risk
T4	AdverseReaction 301 313	malignancies
T5	DrugClass 340 358	immunosuppressants
T7	AdverseReaction 478 520	Progressive Multifocal Leukoencephalopathy
T8	AdverseReaction 522 525	PML
T9	Factor 539 543	risk
T12	AdverseReaction 795 804;835 845	bacterial infections
T13	AdverseReaction 806 811;835 845	viral infections
T14	AdverseReaction 813 819;835 845	fungal infections
T15	AdverseReaction 825 845	protozoal infections
T16	Factor 787 791	risk
T17	AdverseReaction 857 881	opportunistic infections
T18	AdverseReaction 886 898	tuberculosis
T19	AdverseReaction 905 915	infections
T20	AdverseReaction 921 926	fatal
T21	AdverseReaction 1306 1321;1326 1331	Acute Rejection Graft
T22	AdverseReaction 1326 1336	Graft Loss
T23	AdverseReaction 1697 1741	post-transplant lymphoproliferative disorder
T24	AdverseReaction 1743 1747	PTLD
T25	Factor 1677 1681	risk
T26	AdverseReaction 2370 2374	PTLD
T27	Factor 2362 2366	risk
T28	AdverseReaction 4338 4350;4387 4391	malignancies skin
T29	AdverseReaction 4367 4371	PTLD
T30	AdverseReaction 4338 4350	malignancies
T31	AdverseReaction 4895 4898	PML
T32	AdverseReaction 6168 6177;6243 6253	bacterial infections
T33	Factor 6149 6153	risk
T34	AdverseReaction 6179 6184;6243 6253	viral infections
T35	AdverseReaction 6186 6201;6243 6253	cytomegalovirus infections
T36	AdverseReaction 6203 6206;6243 6253	CMV infections
T37	AdverseReaction 6212 6218;6243 6253	herpes infections
T38	AdverseReaction 6233 6253	protozoal infections
T39	AdverseReaction 6221 6227;6243 6253	fungal infections
T40	AdverseReaction 6265 6289	opportunistic infections
T42	AdverseReaction 6297 6307	infections
T41	Severity 6320 6327	serious
T43	AdverseReaction 6339 6344	fatal
T44	AdverseReaction 6613 6625	Tuberculosis
T45	AdverseReaction 7013 7021	JC virus
T46	AdverseReaction 7090 7126	polyoma virus-associated nephropathy
T47	AdverseReaction 7128 7132	PVAN
T48	AdverseReaction 7149 7167	BK virus infection
T49	AdverseReaction 7189 7193	PVAN
T50	AdverseReaction 7241 7269	deteriorating renal function
T51	AdverseReaction 7274 7291	kidney graft loss
T52	AdverseReaction 7990 8000	graft loss
T53	AdverseReaction 8005 8010	death
T54	AdverseReaction 8078 8082	PTLD
T55	AdverseReaction 8118 8123	fatal
T56	AdverseReaction 8133 8138	fatal
T57	AdverseReaction 8147 8150	PML
T58	AdverseReaction 8228 8232	PTLD
T59	AdverseReaction 8299 8304	fatal
T60	AdverseReaction 8313 8316	PML
T61	AdverseReaction 8691 8706;8758 8773	post-transplant acute rejection
T62	Severity 8788 8797	Grade III
T63	AdverseReaction 8477 8482;8825 8835	Graft rejections
T64	AdverseReaction 8885 8890;8927 8936	Graft rejection
T65	AdverseReaction 8885 8895	Graft loss
T66	AdverseReaction 928 964	Polyoma virus-associated nephropathy
T67	AdverseReaction 977 994	kidney graft loss
T68	Factor 965 968	can
T69	AdverseReaction 8691 8706;8758 8773	post-transplant acute rejection
T70	Severity 8815 8824	Grade III
T71	Severity 8917 8926	Grade III
T10	AdverseReaction 764 774	infections
T11	Severity 756 763	serious
T72	AdverseReaction 7033 7036	PML
E1	AdverseReaction:T1 Hypothetical:E3
E2	AdverseReaction:T2 Hypothetical:E3
E3	Factor:T3
E4	AdverseReaction:T4 Hypothetical:E5
E5	DrugClass:T5
E7	AdverseReaction:T7 Hypothetical:E9
E8	AdverseReaction:T8 Hypothetical:E9
E9	Factor:T9
E12	AdverseReaction:T12 Hypothetical:E16
E13	AdverseReaction:T13 Hypothetical:E16
E14	AdverseReaction:T14 Hypothetical:E16
E15	AdverseReaction:T15 Hypothetical:E16
E16	Factor:T16
E17	AdverseReaction:T17 Hypothetical:E16
E18	AdverseReaction:T18 Hypothetical:E16
E19	AdverseReaction:T19
E20	AdverseReaction:T20
E21	AdverseReaction:T21
E22	AdverseReaction:T22
E23	AdverseReaction:T23 Hypothetical:E25
E24	AdverseReaction:T24 Hypothetical:E25
E25	Factor:T25
E26	AdverseReaction:T26 Hypothetical:E27
E27	Factor:T27
E29	AdverseReaction:T29
E28	AdverseReaction:T28
E30	AdverseReaction:T30
E31	AdverseReaction:T31
E32	AdverseReaction:T32 Hypothetical:E33
E33	Factor:T33
E34	AdverseReaction:T34 Hypothetical:E33
E35	AdverseReaction:T35 Hypothetical:E33
E36	AdverseReaction:T36 Hypothetical:E33
E37	AdverseReaction:T37 Hypothetical:E33
E38	AdverseReaction:T38 Hypothetical:E33
E39	AdverseReaction:T39 Hypothetical:E33
E40	AdverseReaction:T40 Hypothetical:E33
E41	AdverseReaction:T42
E42	Severity:T41
E43	AdverseReaction:T42 Effect:E42
E44	AdverseReaction:T43
E45	AdverseReaction:T44
E46	AdverseReaction:T45
E47	AdverseReaction:T46
E48	AdverseReaction:T47
E49	AdverseReaction:T48
E50	AdverseReaction:T49
E51	AdverseReaction:T50
E52	AdverseReaction:T51
E53	AdverseReaction:T52
E54	AdverseReaction:T53
E55	AdverseReaction:T54
E56	AdverseReaction:T55
E57	AdverseReaction:T56
E58	AdverseReaction:T57
E59	AdverseReaction:T58
E60	AdverseReaction:T59
E61	AdverseReaction:T60
E62	AdverseReaction:T61 Effect:E63
E63	Severity:T62
E64	AdverseReaction:T63 Effect:E71
E65	AdverseReaction:T64 Effect:E72
E66	AdverseReaction:T65
E67	AdverseReaction:T66
E68	AdverseReaction:T67 Hypothetical:E69
E69	Factor:T68
E70	AdverseReaction:T69
E71	Severity:T70
E72	Severity:T71
E10	AdverseReaction:T10 Effect:E11
E11	Severity:T11
E73	AdverseReaction:T72
A1	CUI E1 C0432487
A2	UMLS-Preferred-Name E1 Post-transplant lymphoproliferative disorder
A3	MEDDRA-PT E1 Post transplant lymphoproliferative disorder
A4	MEDDRA-PT-ID E1 10051358
A5	CUI E2 C0432487
A6	UMLS-Preferred-Name E2 Post-transplant lymphoproliferative disorder
A7	MEDDRA-PT E2 Post transplant lymphoproliferative disorder
A8	MEDDRA-PT-ID E2 10051358
A9	CUI E4 C0006826
A10	UMLS-Preferred-Name E4 Malignant Neoplasms
A11	MEDDRA-PT E4 Neoplasm malignant
A12	MEDDRA-PT-ID E4 10028997
A13	CUI E7 C0023524
A14	UMLS-Preferred-Name E7 Leukoencephalopathy, Progressive Multifocal
A15	MEDDRA-PT E7 Progressive multifocal leukoencephalopathy
A16	MEDDRA-PT-ID E7 10036807
A17	CUI E8 C0023524
A18	UMLS-Preferred-Name E8 Leukoencephalopathy, Progressive Multifocal
A19	MEDDRA-PT E8 Progressive multifocal leukoencephalopathy
A20	MEDDRA-PT-ID E8 10036807
A21	CUI E12 C0004623
A22	UMLS-Preferred-Name E12 Bacterial Infections
A23	MEDDRA-PT E12 Bacterial infection
A24	MEDDRA-PT-ID E12 10060945
A25	CUI E13 C0042769
A26	UMLS-Preferred-Name E13 Virus Diseases
A27	MEDDRA-PT E13 Viral infection
A28	MEDDRA-PT-ID E13 10047461
A29	CUI E14 C0026946
A30	UMLS-Preferred-Name E14 Mycoses
A31	MEDDRA-PT E14 Fungal infection
A32	MEDDRA-PT-ID E14 10017533
A33	CUI E15 C0033740
A34	UMLS-Preferred-Name E15 Protozoan Infections
A35	MEDDRA-PT E15 Infection protozoal
A36	MEDDRA-PT-ID E15 10021859
A37	CUI E17 C0029118
A38	UMLS-Preferred-Name E17 Opportunistic Infections
A39	MEDDRA-PT E17 Opportunistic infection
A40	MEDDRA-PT-ID E17 10030901
A41	CUI E18 C0041296
A42	UMLS-Preferred-Name E18 Tuberculosis
A43	MEDDRA-PT E18 Tuberculosis
A44	MEDDRA-PT-ID E18 10044755
A45	CUI E19 C3714514
A46	UMLS-Preferred-Name E19 Infection
A47	MEDDRA-PT E19 Infection
A48	MEDDRA-PT-ID E19 10021789
A49	CUI E20 C1306577
A50	UMLS-Preferred-Name E20 Death (finding)
A51	MEDDRA-PT E20 Death
A52	MEDDRA-PT-ID E20 10011906
A53	CUI E21 C1736177
A54	UMLS-Preferred-Name E21 Acute graft rejection
A55	MEDDRA-PT E21 Transplant rejection
A56	MEDDRA-PT-ID E21 10044439
A57	LLT E21 Acute graft rejection
A58	LLT-ID E21 10066615
A59	CUI E22 C0877042
A60	UMLS-Preferred-Name E22 Graft loss
A61	MEDDRA-PT E22 Graft loss
A62	MEDDRA-PT-ID E22 10048748
A63	CUI E23 C0432487
A64	UMLS-Preferred-Name E23 Post-transplant lymphoproliferative disorder
A65	MEDDRA-PT E23 Post transplant lymphoproliferative disorder
A66	MEDDRA-PT-ID E23 10051358
A67	CUI E24 C0432487
A68	UMLS-Preferred-Name E24 Post-transplant lymphoproliferative disorder
A69	MEDDRA-PT E24 Post transplant lymphoproliferative disorder
A70	MEDDRA-PT-ID E24 10051358
A71	CUI E26 C0432487
A72	UMLS-Preferred-Name E26 Post-transplant lymphoproliferative disorder
A73	MEDDRA-PT E26 Post transplant lymphoproliferative disorder
A74	MEDDRA-PT-ID E26 10051358
A75	CUI E28 C0007114
A76	UMLS-Preferred-Name E28 Malignant neoplasm of skin
A77	MEDDRA-PT E28 Skin cancer
A78	MEDDRA-PT-ID E28 10040808
A79	LLT E28 Skin neoplasm malignant
A80	LLT-ID E28 10040895
A81	CUI E29 C0432487
A82	UMLS-Preferred-Name E29 Post-transplant lymphoproliferative disorder
A83	MEDDRA-PT E29 Post transplant lymphoproliferative disorder
A84	MEDDRA-PT-ID E29 10051358
A85	CUI E30 C0006826
A86	UMLS-Preferred-Name E30 Malignant Neoplasms
A87	MEDDRA-PT E30 Neoplasm malignant
A88	MEDDRA-PT-ID E30 10028997
A89	CUI E31 C0023524
A90	UMLS-Preferred-Name E31 Leukoencephalopathy, Progressive Multifocal
A91	MEDDRA-PT E31 Progressive multifocal leukoencephalopathy
A92	MEDDRA-PT-ID E31 10036807
A93	CUI E32 C0004623
A94	UMLS-Preferred-Name E32 Bacterial Infections
A95	MEDDRA-PT E32 Bacterial infection
A96	MEDDRA-PT-ID E32 10060945
A97	CUI E34 C0042769
A98	UMLS-Preferred-Name E34 Virus Diseases
A99	MEDDRA-PT E34 Viral infection
A100	MEDDRA-PT-ID E34 10047461
A101	CUI E35 C0010823
A102	UMLS-Preferred-Name E35 Cytomegalovirus Infections
A103	MEDDRA-PT E35 Cytomegalovirus infection
A104	MEDDRA-PT-ID E35 10011831
A105	CUI E36 C0010823
A106	UMLS-Preferred-Name E36 Cytomegalovirus Infections
A107	MEDDRA-PT E36 Cytomegalovirus infection
A108	MEDDRA-PT-ID E36 10011831
A109	LLT E36 CMV infection
A110	LLT-ID E36 10009703
A111	CUI E37 C0019372
A112	UMLS-Preferred-Name E37 Herpesviridae Infections
A113	MEDDRA-PT E37 Herpes virus infection
A114	MEDDRA-PT-ID E37 10019973
A115	LLT E37 Herpes infection
A116	LLT-ID E37 10019941
A117	CUI E38 C0033740
A118	UMLS-Preferred-Name E38 Protozoan Infections
A119	MEDDRA-PT E38 Infection protozoal
A120	MEDDRA-PT-ID E38 10021859
A121	CUI E39 C0026946
A122	UMLS-Preferred-Name E39 Mycoses
A123	MEDDRA-PT E39 Fungal infection
A124	MEDDRA-PT-ID E39 10017533
A125	CUI E40 C0029118
A126	UMLS-Preferred-Name E40 Opportunistic Infections
A127	MEDDRA-PT E40 Opportunistic infection
A128	MEDDRA-PT-ID E40 10030901
A129	CUI E41 C3714514
A130	UMLS-Preferred-Name E41 Infection
A131	MEDDRA-PT E41 Infection
A132	MEDDRA-PT-ID E41 10021789
A133	CUI E44 C1306577
A134	UMLS-Preferred-Name E44 Death (finding)
A135	MEDDRA-PT E44 Death
A136	MEDDRA-PT-ID E44 10011906
A137	CUI E45 C0041296
A138	UMLS-Preferred-Name E45 Tuberculosis
A139	MEDDRA-PT E45 Tuberculosis
A140	MEDDRA-PT-ID E45 10044755
A141	CUI E46 C0857836
A142	UMLS-Preferred-Name E46 JC virus infection
A143	MEDDRA-PT E46 JC virus infection
A144	MEDDRA-PT-ID E46 10023163
A145	CUI E47 C1696946
A146	UMLS-Preferred-Name E47 Polyomavirus-associated nephropathy
A147	MEDDRA-PT E47 Polyomavirus-associated nephropathy
A148	MEDDRA-PT-ID E47 10065381
A149	CUI E48 C1696946
A150	UMLS-Preferred-Name E48 Polyomavirus-associated nephropathy
A151	MEDDRA-PT E48 Polyomavirus-associated nephropathy
A152	MEDDRA-PT-ID E48 10065381
A153	CUI E49 C1096691
A154	UMLS-Preferred-Name E49 BK virus infection
A155	MEDDRA-PT E49 BK virus infection
A156	MEDDRA-PT-ID E49 10055181
A157	CUI E50 C1696946
A158	UMLS-Preferred-Name E50 Polyomavirus-associated nephropathy
A159	MEDDRA-PT E50 Polyomavirus-associated nephropathy
A160	MEDDRA-PT-ID E50 10065381
A161	CUI E51 C1278220
A162	UMLS-Preferred-Name E51 Deteriorating renal function
A163	MEDDRA-PT E51 Renal impairment
A164	MEDDRA-PT-ID E51 10062237
A165	LLT E51 Function kidney decreased
A166	LLT-ID E51 10017474
A167	CUI E52 C0877690
A168	UMLS-Preferred-Name E52 Renal graft loss
A169	MEDDRA-PT E52 Renal transplant failure
A170	MEDDRA-PT-ID E52 10074495
A171	LLT E52 Renal graft loss
A172	LLT-ID E52 10048749
A173	CUI E53 C0877042
A174	UMLS-Preferred-Name E53 Graft loss
A175	MEDDRA-PT E53 Graft loss
A176	MEDDRA-PT-ID E53 10048748
A177	CUI E54 C1306577
A178	UMLS-Preferred-Name E54 Death (finding)
A179	MEDDRA-PT E54 Death
A180	MEDDRA-PT-ID E54 10011906
A181	CUI E55 C0432487
A182	UMLS-Preferred-Name E55 Post-transplant lymphoproliferative disorder
A183	MEDDRA-PT E55 Post transplant lymphoproliferative disorder
A184	MEDDRA-PT-ID E55 10051358
A185	CUI E56 C1306577
A186	UMLS-Preferred-Name E56 Death (finding)
A187	MEDDRA-PT E56 Death
A188	MEDDRA-PT-ID E56 10011906
A189	CUI E57 C1306577
A190	UMLS-Preferred-Name E57 Death (finding)
A191	MEDDRA-PT E57 Death
A192	MEDDRA-PT-ID E57 10011906
A193	CUI E58 C0023524
A194	UMLS-Preferred-Name E58 Leukoencephalopathy, Progressive Multifocal
A195	MEDDRA-PT E58 Progressive multifocal leukoencephalopathy
A196	MEDDRA-PT-ID E58 10036807
A197	CUI E59 C0432487
A198	UMLS-Preferred-Name E59 Post-transplant lymphoproliferative disorder
A199	MEDDRA-PT E59 Post transplant lymphoproliferative disorder
A200	MEDDRA-PT-ID E59 10051358
A201	CUI E60 C1306577
A202	UMLS-Preferred-Name E60 Death (finding)
A203	MEDDRA-PT E60 Death
A204	MEDDRA-PT-ID E60 10011906
A205	CUI E61 C0023524
A206	UMLS-Preferred-Name E61 Leukoencephalopathy, Progressive Multifocal
A207	MEDDRA-PT E61 Progressive multifocal leukoencephalopathy
A208	MEDDRA-PT-ID E61 10036807
A209	CUI E62 C1736177
A210	UMLS-Preferred-Name E62 Acute graft rejection
A211	MEDDRA-PT E62 Transplant rejection
A212	MEDDRA-PT-ID E62 10044439
A213	LLT E62 Acute graft rejection
A214	LLT-ID E62 10066615
A215	CUI E64 C0018129
A216	UMLS-Preferred-Name E64 Graft Rejection
A217	MEDDRA-PT E64 Transplant rejection
A218	MEDDRA-PT-ID E64 10044439
A219	LLT E64 Graft rejection
A220	LLT-ID E64 10018650
A221	CUI E65 C0018129
A222	UMLS-Preferred-Name E65 Graft Rejection
A223	MEDDRA-PT E65 Transplant rejection
A224	MEDDRA-PT-ID E65 10044439
A225	LLT E65 Graft rejection
A226	LLT-ID E65 10018650
A227	CUI E66 C0877042
A228	UMLS-Preferred-Name E66 Graft loss
A229	MEDDRA-PT E66 Graft loss
A230	MEDDRA-PT-ID E66 10048748
A231	CUI E67 C1696946
A232	UMLS-Preferred-Name E67 Polyomavirus-associated nephropathy
A233	MEDDRA-PT E67 Polyomavirus-associated nephropathy
A234	MEDDRA-PT-ID E67 10065381
A235	CUI E68 C0877690
A236	UMLS-Preferred-Name E68 Renal graft loss
A237	MEDDRA-PT E68 Renal transplant failure
A238	MEDDRA-PT-ID E68 10074495
A239	LLT E68 Renal graft loss
A240	LLT-ID E68 10048749
A241	CUI E70 C1736177
A242	UMLS-Preferred-Name E70 Acute graft rejection
A243	MEDDRA-PT E70 Transplant rejection
A244	MEDDRA-PT-ID E70 10044439
A245	LLT E70 Acute graft rejection
A246	LLT-ID E70 10066615
A247	CUI E10 C3714514
A248	UMLS-Preferred-Name E10 Infection
A249	MEDDRA-PT E10 Infection
A250	MEDDRA-PT-ID E10 10021789
A251	CUI E73 C0023524
A252	UMLS-Preferred-Name E73 Leukoencephalopathy, Progressive Multifocal
A253	MEDDRA-PT E73 Progressive multifocal leukoencephalopathy
A254	MEDDRA-PT-ID E73 10036807
